• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Aegerion`s Biologic Yyalipt (Metreleptin) Receives Approval in the U.S.

    FDA

    Aegerion`s Biologic Myalept (Metreleptin) Receives Approval in the U.S.

    FDA

    Aegerion`s Biological Metreleptin Receives Approval In US

    FDA

    Aegerion`s Myalept ( Metreleptin) Receives Supplemental Approval in US

    FDA

    Aegerion`s Metreleptin Receives Supplemental Approval in US

    FDA

    Aegerion Pharmaceuticals BV`s Myalepta(metreleptin) Receives Approval in Europe

    EMA

    Aegerion’s Myaleptr (Metreleptin) Receives Supplemental Approval In US

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.